Say YES to Hope and SMGlobal Catwalk make dreams come true for stage 4 cancer patients as they model during SMGlobal Dallas Revolution.

Live webinar on Thursday, October 11, 2018 to examine the adoption of basket and umbrella trials in oncology drug development

Data validity is the cornerstone of evidence-based medicine. As randomized controlled trials are augmented by real-world evidence, data validity has come under question.

Florence, a fast-growing Atlanta based company building software that advances clinical research, has been named one of the top 100 Best Places to Work in 2018 by the Atlanta Business Chronicle. Florence was named the #11 best place to work in the small business category.

What does it mean to have a truly site-centric supply chain? In the past, site forecasting was considered avoiding stock-out. This is no longer the case.

CROs are finding themselves operating in an increasingly competitive market, where true differentiation is hard to achieve. In order to stand out from the competition, today's CROs need to offer something more.

Annual Prestigious Prize Worth $35,000 Drives Critical Research Area

PD-L1 expression measured by immunohistochemistry helps identify non-small cell lung cancer (NSCLC) patients that may respond to anti-PD-1/PD-L1 immunotherapies.

Learn to instill quality and efficiencies into a clinical database from beginning to end

On average, psychiatric drugs entering Phase I fail to achieve approval 94 percent of the time. Is poor data quality playing a role?

One of America's foremost oncologists leads this webinar series on the past, the present and the future of immunotherapy studies

A Strategic, Technology-Driven Approach

The focus on technology as a driver of performance improvement in clinical trials is intense, but despite years of valiant efforts, study execution remains far from optimal - for study startup, the data are dismal

Industry experts will tackle the challenge of recruiting patients with early stage Alzheimer's disease into clinical trials to expedite treatment development

This clinical trials-related webinar will provide background on heavy menstrual bleeding (HMB) and discuss HMB trials from the PI and patient perspectives

FocalView will be used in a first-of-its-kind study to collect electronic Device Reported Outcome (eDRO) measurements.

Session will help practitioners understand the benefits of using the tool and how organizations can proactively manage receipt acknowledgements, oversee distribution from a user-friendly dashboard and increase overall compliance in a cost-effective way through automation

Florence announces over 2,000 clinical trial sites are now using Florence eBinders to accelerate studies with eRegulatory and eSource.

According to the 2017 Tufts eClinical Landscape Study, 97% of companies plan to increase use of at least one clinical data source over the next three years. But today, 98% of companies report challenges with their clinical data management systems.

The race is on for non-alcoholic steatohepatitis (NASH) drug development as the disease—which has no approved treatments—is rapidly growing in prevalence and is the fastest rising cause of liver transplantation in the United States.

Bring your own device (BYOD) solutions offer a disruptive alternative to the costly provisioned solutions for ePRO but have been mostly overlooked and only moderately considered due, in part, to this question of equivalence and to concerns for patients accepting study tools on their own phones.

Webinar describes how Agios Pharmaceuticals is solving business and data challenges by implementing a Clinical Data Hub including key selection criteria, implementation best practices, and lessons learned.

At the summit, international participants from leading cancer centers discussed the application of Alpha DaRT to various cancer types.

Patient engagement experts from Bracket and Boehringer-Ingelheim to discuss technology selection and implementation strategies for clinical trials.

Experts from Comprehend and Tufts CSDD to discuss the recent study, outline where the industry is headed and ways to overcome oversight challenges including transparency, risk, and compliance

Presenters discuss how clinical innovators, Market Access, IT and HEOR can accelerate RWE initiatives and the implications for data security and healthcare decision-making

Presented by Covance Chief Scientific Officer Steve Anderson, Ph.D., and Covance Global Leader, Precision Medicine and Head, Biomarker Solution Center, Suso Platero, Ph.D., this webinar will address the spectrum of immunotherapy development considerations and their implications for drug developers.